Bevacizumab in the treatment of radiation injury for children with central nervous system tumors.

Nathan A DahlArthur K LiuNicholas K ForemanMelissa WidenerLaura Z FentonMargaret E Macy

Published in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2019)

Our experience lends support to the safety and feasibility of bevacizumab administration for the treatment of radiation necrosis for appropriately selected patients within the pediatric population.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
young adults
prognostic factors
metastatic colorectal cancer
radiation induced
patient reported outcomes